Quarterly Earnings

Entravision's ad-tech unit soared 230% on AI, driving record profit. But with its legacy media arm in decline, can this tech pivot redefine its future?

Facing a 50% revenue collapse and mounting losses, The Arena Group is rebranding to Paradium.AI, a high-stakes pivot to save itself with technology.

In a blockbuster deal with Boeing, Archer acquires key assets to build a 'physical AI' powerhouse. But with soaring losses, is it a masterstroke or a costly bet?

Fluent's Q2 results reveal a dramatic pivot, with Commerce Media Solutions booming 90%. But can this growth and a new in-store bet outrun a stark 'going concern' warning?

Strong Attruby sales and new data showing superiority fuel BridgeBio’s momentum as it prepares for three FDA decisions, backed by a new $1B financing.

Freedom Holding Corp. posts a 40% revenue jump but a drop in net income, signaling an aggressive, high-cost strategy centered on its SuperApp and major acquisitions.

A shocking $90M guidance cut and a securities probe at Myriad Genetics reveal more than a bad quarter; they expose deep cracks in the genetic testing market.

AGCO's stock plunged after a surprise guidance cut, triggering a legal probe. We dissect if this was just a market downturn or a failure in transparency.

Outdoor Holding Company's Q1 results show a stunning recovery. With revenue up 22% and profits secured, its GunBroker platform is outperforming the market.

Heron Therapeutics withdraws guidance after a patent blow to its top drug, forcing a strategic review. Can strong growth in new acute care products save it?

Revenue missed and its stock plunged, but Quanterix is betting on a new C-suite and its Alzheimer's test to navigate market headwinds and deliver on its promise.

Amid its pending sale to Zymeworks, Theravance Biopharma’s Q2 results reveal a lesson in resilience, with strong YUPELRI sales and deep cost cuts.

Strive, Inc. reports a massive Q2 loss on paper, but a closer look reveals a debt-free company doubling down on Bitcoin and launching a daily dividend.

The work management giant posted strong Q2 results but is betting its future on a radical AI pivot, cutting staff to fund a new era of automated execution.

CECO Environmental's record quarter, fueled by a mega-acquisition, reveals a complex story of ambition, financial nuance, and a strategic pivot to dominate.

With eight straight quarters of growth, Citi Trends' success isn't just about off-price value. It's a masterclass in strategic focus on a core demographic.

Amid MENA turmoil, NESR posts a 190% profit surge. A deep dive into the strategy of leveraging specialized services and key contracts to thrive.

Amid rising costs, Northview Residential REIT holds firm by refinancing debt, shedding old assets, and doubling down on high-growth Canadian Northern markets.

The safari park operator's Q3 results reveal a complex story. While one park shines, rising costs and a sharp drop in capital spending raise questions.

A massive earnings jump masks underlying operational costs. HEI leverages its wildfire settlement clarity to launch a huge renewable energy and grid hardening plan.